Also trades as: 0LB2.L (LSE) · $vol 0M
SUPN NASDAQ
Supernus Pharmaceuticals, Inc.
1W: -3.5%
1M: -1.8%
3M: -2.9%
YTD: -0.2%
1Y: +48.7%
3Y: +40.4%
5Y: +61.7%
$48.21
-1.17 (-2.37%)
Weekly Expected Move ±5.0%
$44
$47
$49
$52
$54
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$777M
Revenue
+16.3% YoY
$-29M
Net Income
-146.9% YoY
$82M
Free Cash Flow
-49.6% YoY
88.7%
Gross Margin
-3.6%
Op. Margin
-1.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-2.8%
ROA-2.1%
ROIC-4.1%
Valuation
P/E-95.8
P/B2.6
EV/EBITDA64.1
Leverage
Debt/Equity0.04
Current Ratio1.90
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z5.74
Beneish M-2.47